发明名称 Oxazolidinone-quinolone hybrid antibiotics
摘要 The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:;
申请公布号 US9133213(B2) 申请公布日期 2015.09.15
申请号 US201313933811 申请日期 2013.07.02
申请人 Morphochem Aktiengesellschaft Für Kombinatorische Chemie 发明人 Hubschwerlen Christian;Specklin Jean-Luc;Baeschlin Daniel;Schmitt Christine;Müller Stefan;Cappi Michael W.
分类号 C07D471/04;C07D498/06;C07D413/12;C07D413/14;C07F9/6558;C07F9/6561 主分类号 C07D471/04
代理机构 Locke Lord LLP 代理人 Locke Lord LLP ;DiCeglie, Jr. Nicholas J.
主权项 1. A compound of formula (I) wherein A is C1-6 alkylene, C2-6 alkenylene, C2-6 alkynylene or C1-6 heteroalkylene; Q is CR4; X is CR7 or N; Y is CH; n is 1, 2 or 3; m is 1, 2 or 3; R1 is H, F, Cl, Br, I, OH, NH2, an alkyl group or a heteroalkyl group; R2 is H, F or Cl; R3 is an ethyl, a 2-propyl, a C3-C6cycloalkyl, a phenyl or a pyridyl group; all of which may be substituted with one, two, three or more fluorine atoms or amino groups; R4 is hydroxyl or a group of formula OSO3H, OPO3H2, OCH2OPO3H2, or OCOCH2CH2COOH; R5 is selected from the following groups: R6 is H, F, Cl or OMe; R7 is H, F, Cl or a methoxy group which may be substituted by one, two or three fluorine atoms; or R7 and R3 together form a bridge of the formula —O—CH2—N(Me)- or —O—CH2—CH(Me)-; and R8 is a C1-6 heteroalkyl group; or a pharmacologically acceptable salt, solvate, hydrate or formulation thereof.
地址 München DE